This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk01: Hello, ladies and gentlemen. Thank you for standing by for ZEPP Health Corps' first quarter 2022 earnings conference call. At this time, all participants are in listen-only mode. Today's conference call is being recorded. I will now turn the call over to your host, Ms. Grace Zong, Director of Investor Relations for the company. Please go ahead, Grace.
spk02: Hello, everyone, and welcome to ZEPP Health Corporation's first quarter 2022 earnings conference call. The company's financial and operating results were issued in a press release by Newswire Services earlier today and are posted online. You can also view the earnings press release and the slides which we will refer on this call by visiting the IR session of the company's website at ir.zap.com. Participating in today's call are Mr. Huang Wang, our Chairman of the Board of Directors and Chief Executive Officer. and Mr. Liang Zheng, our chief financial officer. The company's management will begin with prepared remarks, and the call will conclude with a Q&A session. Mr. Mike Yang, our chief operating officer, will join the call for the Q&A session. Before we continue, please note that today's discussion will contain forward-looking statements under the safe harbor provision of the U.S. private securities Litigation Reform Act of 1995. Forward-looking statements involve inherent risks and uncertainties. As such, the company's actual results may be materially different from the views expressed today. Further information regarding this and other risks and uncertainties is included in the company's annual report on Form 20-F for the fiscal year ended December 31, 2021. and other filings as filed with the U.S. Securities and Exchange Commission. The company does not assume any obligation to update any forward-looking statements except as required under applicable law. Please also note that ZEPP's earnings press release and this conference call include discussion of unaudited gap financial information as well as unaudited non-gap financial information. ZEPP's press release contains reconciliation of the unaudited non-GAAP measures to the unaudited most directly comparable GAAP measures. I'll now turn the call over to our CEO, Mr. Huang Wang. Please go ahead.
spk04: Hello, everyone. Thank you for joining our call. The last several months have been challenging given the ongoing COVID-19 pandemic, compounded by geopolitical unrest. Against these backdrops, we are pleased that our first quarter revenue came in, aligned with our guidance. We achieved $0.8 billion in revenue, representing a decrease of 34% year-over-year. Our revenue was affected by the decrease in Mi Band 6 treatment, as consumers are waiting for the new generation Mi Band launch. as well as reduce discretionary spending as consumers cut back amidst the inflationary environment. Supply chain and logistic interruptions due to lockdowns and other restrictions as part of the pandemic prevention and control measures in China also impacted our first quarter. We should highlight, however, that the first quarter has also typically been a slow quarter for sales due to seasonality. Despite all these headwinds, we were also pleased to see that our revenue mix continued to shift towards our self-branded products, which now contributes more than 65% of our total revenue. demonstrates once again the broad appeal of our products as we focus on connecting health with technology to enhance users' lifestyles and help them effectively manage their health conditions. To further build out our sales channels, we continue to expand and deepen our partnerships with large retail outlets in the overseas markets. As a result, we showed particularly strong performance in North American region, where our self-branded product revenue surged by more than 110% year over year. These achievements are a testament not only to our own successful operations despite challenges and uncertainties, but also to the lifestyle evolution we are part of. with healthcare services supported by smart wearable devices, transforming people's daily lives. We expect the undeniable benefits of smart wearable devices coupled with innovations in software, sensors, and other hardware to provide continued tailwinds to our future growth. As we strive to be a leader in this megatrend. We have been working relentlessly to harness the power of technology to enhance our products and have established a comprehensive AI algorithm system encompassing sensors plus health big data, which we incorporate into our product designs to help our users realize their health and fitness goals. To that end, we are preparing to unveil our next-generation smartwatches. Today, we launched our upgraded outdoor watch, T-Leg 2, this enhanced dual-frequency GPS. Later this year, we will also upgrade our most popular GTS and GTR and BIP series as newcomers to our basic and sport product lines. These devices both meaningful multi-dimensional enhancements in health-related functionalities, style, and algorithms, among others. Additionally, we continuously upgrade and add new features to our existing products to enhance user experience. For example, we wrote out a firmware update for Amazfit GTR3 and GTS3 series devices in late April and added a text response function for incoming calls, as well as optimization for the alarm clock feature, music downloads, and system stability. We also recently made meaningful inroads in our exploration of the medical grade healthcare industry. and launched the first product in our smart hearing aid product line, ZAP Clarity One, an adjustable, comfortable, invisible, and discreet device for those with hearing loss, and especially for those who don't want others to notice. Notably, ZAP Clarity One offers more than just a device. It also comes with a customer-first, best-in-class support team guided by audiology professionals to ensure the best possible experience for users. Last but not least, our collaboration with Xiaomi continues to be fruitful. Just today, we launched Mi Band 7, and we look forward to building on the previous processes of the past generations of this powerful product line and taking its journey one step further. As we remain committed to connecting health with technology, we continue to drive technological innovation through collaboration with universities and by engaging our user community. with the University of Science and Technology of China, we launched our first ZAP OS Technology and Health Campus Innovation Contest, inspiring students to develop apps for smart wearables devices that can improve people's health management habits. We also collaborate with UC Berkeley on their Caltech events, to encourage users worldwide to join our ZapOS ecosystem. The core values that we hold dearly here at Zap will continue to help our users better manage their health and wellness and design their lives by healthy choices. Our inclusive and innovative ZapOS ecosystem has drawn, developed, globally to design apps and watch faces on our platform, contributing to a flourishing user community that is more vibrant than ever. To conclude, we are making progress amidst the macro economy uncertainties. Going forward, we will continue to invest in and capture the enormous opportunities in the healthcare services industry by focusing on technological innovations in AI chips, health big data, and algorithms, as well as our product portfolio expansion. Despite the short-term impact from geopolitical conflicts, the pandemic resurgence, and the associated supply chain and logistic challenges, We are very excited about ZAP's long-term prospects as we remain dedicated to shaping the technologies of tomorrow while meeting the needs of our users today. With that, I will now turn the call over to Leon to go over highlights of our first quarter financial results.
spk07: Thank you, Wong. I would like to start by highlighting some of the key metrics driving ZEPS development. Before providing further details on our financial performance, I would like to briefly elaborate on the macro environment issues we have faced so far in 2022, which is shaping up to be a year packed with challenges. The Q1 2022 lockdowns of China's Tianjin and Shenzhen ports in addition to the significant disruptions in March 2022 to our export route through Shenzhen into Hong Kong vital to our global supply chain and product availability, has interrupted our deliveries and sales worldwide. Furthermore, the pandemic-related restrictions in the Yangtze River Delta since March also had some impact on our supply chain in early Q2. Moreover, The global semiconductor shortage continues to constrain our supply chain, albeit our supply chain team has been working hard in seeking alternative solutions to resolve the ongoing situation. Separately, escalating geopolitical strife among countries, notably the conflict between Russia and Ukraine, is creating turbulence, damping consumer confidence, causing inflation, which all led to a slowdown in consumer discretionary spending. These adverse conditions weighed on our revenues generated and our overall gross margin. Together, these factors have affected our Q1 results and continue to impact our ongoing Q2 2022 performance. Despite these ongoing headwinds in 2022, we reported revenue of RMB 0.8 billion in Q1. It comes within our guidance range against a very difficult macro environment. Our revenue was down 34% compared with Q1 2021. Again, the decrease was mostly driven by the decrease in the banned sales. In the meantime, COVID-19 and chip shortages also constrained the growth of our self-branded products. I have to say that we are very proud of our self-branded products performance, especially in light of all these headwinds. Our self-branded products contributed over 65% of the total revenue of the quarter. We believe our self-branded products will continue to gain momentum as we further develop our product capabilities and enhance our brand's market recognition globally. Now let's look at gross margin. which can be affected by product mix, product launch timing, and product life cycles, including model upgrades. Our first quarter 2022 gross margin was 20.1%, compared with 22.5% for the first quarter of 2021, and 19.3% for the fourth quarter of 2021. The lower gross margin versus last year was mostly affected by the increasing freight costs aimed at pandemic while the improvement versus Q4 2021 was supported by refinements to our product mix, including an increased proportion of cell-branded products. Turning now to costs, which has been a key focal point of mine, both in terms of absolute amounts as well as the percentage of sales. A portion of operating expenses are fixed, so it takes time and creativity to gradually reduce these expenses. While we have to carefully balance our cost controls with expenditures to fuel growth, I'm pleased to report that we have already seen a decreasing trend in total operating expenses since Q3 2020. Going forward, we'll continue to right-size our operating expenses from their current level in order to deliver profitable growth in the following quarters. First quarter 2022 operating expenses decreased slightly in absolute terms, compared with the same period in 2021. However, at 40.6% of sales, they represented a percentage increase when compared with the first quarter of 2021, during which operating expenses were 26.9% of sales. This was mostly driven by the lower top line. Given the headwinds I just explained above, we're consistently streamlining costs to protect future profitability. has spending on research and R&D in Q1 2022 was R&D 146.4 million, a decrease of 3.9% year over year, though given the low revenue levels comprise 19.3% of revenue versus 13.3% for the same period. The lower spending absolute terms reflects our effective R&D expenses controls. Q1 2022 selling and marketing expenses were RMB 103.1 million, an increase of 13.6% year-over-year, comprising 13.6% of revenue, compared with 7.9% of the revenue for the same period in 2021, mainly due to higher advertising and promotions for self-branded products and the increase of overseas sales personnel to serve the local markets. G&A expenses were RMB 58.2 million in the first quarter of 2022, representing a decrease of 10.9% year-over-year, largely due to effective cost controls. It accounted for 7.7% of revenue compared with 5.7% in the same period in 2021. Regarding net income, The first quarter of 2022 saw an adjusted net loss of RMB 75.7 million compared with the adjusted net loss of RMB 29.0 million for the first quarter of 2021. Now turning to balance sheet. As the Shenzhen lockdown in March impeded key component supply, hence our production, our inventories grow in Q1 2022 by RMB 281.3 million versus December 31st, 2021. We are optimistic the chip shortage and oversupply chain issues will start to ease in the second half of this year. And despite the challenging circumstances, our balance sheet remains robust. Cash and cash equivalents as of March 31st, 2022 was RMB 1.02 billion compared with RMB 1.09 billion as of March 31, 2021, as we continue to implement disciplined working capital management practices. In November 2021, the Board approved the allocation of up to U.S. dollars 20 million toward a shared repurchase program. In Q1 2022, we continued the repurchase program, reflecting our confidence in our growth strategy and financial performance. We have bought back US dollars 6.9 million worth of shares until March 31st, 2022, and intend to carry on with this buyback program. In addition, the company paid out the special dividends for 2021 to ADS holders on April 15th, 2022. Lastly, moving to our outlook. Due to the ongoing challenges, our outlook for the second quarter of 2022 currently projects net revenue to be between RMB 1.08 billion and RMB 1.3 billion, compared with RMB 1.84 billion in the second quarter of 2021. The second quarter performance is very much driven by new product launch timing. As the Mi Band 6 was launched in March 2021, while Mi Band 7 launched today, May 24th, 2022. This outlook also reflects the continued uncertainty of the potential effects of COVID-19 pandemic on sales and electric component delays, as well as the lower discretionary consumer spending. Given this outlook, we'll continue to apply strict cost control measures and discipline the working capital management through 2022. Please note, though, that our outlook is based on existing market conditions and reflects the management's current and preliminary estimates of the market and operating conditions, as well as customer demand, which are all subject to change. This concludes our prepared remarks. We'll now open the call to questions. Operator, please go ahead.
spk01: We will now begin the question and answer session. To ask a question, you may press star then 1 on your telephone keypad. If you're using a speakerphone, please pick up your handset before pressing the keys. To withdraw your question, please press star then 2. At this time, we will pause momentarily to assemble our roster. And please know, for the benefit of all participants on today's call, if you wish to ask your question to the company's management in Chinese, please immediately repeat your question in English. Our first question will come from Yan Luo with PF Securities. You may now go ahead.
spk06: Thank you. Thank you for taking my question and congratulations for first quarter. First of all, can you share some view about the impact by the COVID in Shanghai? Because I find that the COVID is very serious in this time. I mean, and the impact about your operation and supply chain and custom. Thank you.
spk07: Yeah, thank you very much. The impact of Shanghai is relatively small to us versus the impact on Shenzhen, right? Because most of our supply chain and factories are based out of southern China rather than the Yangtze Delta River area, which I just mentioned. However, we do have one of our factories in Suzhou, which is actually creating or making some new products for our company as well. Since the lockdown was kind of constrained within Shanghai, the impact is relatively limited to us for Shanghai as a region. However, Since Shanghai was among one of the top cities in China, there's a lot of consumers who are purchasing our watches. And the two months lockdown in Shanghai obviously dampens the sales outlook for our Q1 as well as our Q2 sales for China. But however, we'll try to promote our products across China in different regions so that we could compensate for the shuffle in Shanghai.
spk06: Okay. Thank you. And the second question is about the market change. So we see the global political development change day by day, and we see that food price is raising in some emerging markets. So how do you forecast the consumer electronics market and the smartwatch market next year?
spk07: So, yeah, it's a good question. We do notice that there's a few issues, which I mentioned also in the script, that we do see some slowdown in Russia and Ukraine as a specific market. And we do see the slowdown on consumer discretionary income in markets like Europe and also in United States. We see that people's discretionary income is very much squeezed to some extent by the inflation. So overall, there is a certain degree of a decrease on the discretionary spend from the consumers. However, we also see some interesting signs of our brands actually taking over other brands. For example, in the United States and also in certain parts of Europe, we're performing better than the others. The future is still a very fluid picture. As you can see that in our guidance, our Q2 number is already much better than our Q1 number. And then we do have high hopes that in Q3 and Q4, together with our new product launches on the whole year level, we should still have at least similar level of the revenue as 2021 or even with a single digit growth to that extent. But this is all very early for us to predict. If you look at the growth of the smartwatch market, at least from the IDC report, which we see at this moment in time, which probably doesn't reflect the latest insights we have, they are still pointing to a growth of the overall market in the years to come. So we're still relatively optimistic about the wearables market, which we operated in as well.
spk06: Okay, okay, okay. Thank you. Thank you.
spk01: Our next question will come from Kevin Chang with China Renaissance. You may now go ahead.
spk03: Hi, thank you management for taking my question. And congratulations on the good results. I have a question regarding your upcoming outlook Since your guidance for 2Q, it's pointing to a very strong Q&Q rebound growth. Would you categorize this as mostly driven by the new Mi Band product or also our own brand product as well? And how do we see, let's say, the Xiaomi-related revenue contribution I think this past quarter was only down to about 35%. How do you see this trend going forward for the rest of the year? Thank you.
spk07: Yeah, it's a good question. So on the outlook, as I said, Q2 is already pointing on a strong quarter-on-quarter rebound. And our quarterly number is very much linking to the new product launch time. As I said just now, Xiaomi 6, the launch time was March last year, and then in Q2, you actually can count for a full quarter, which was the fact in last year. But this year, the new Mi Band 7 was only launched now, and we will start selling as per June 1st. So we can only count for the new product sales for a month instead of a whole quarter. So that actually kind of explains the difference between Q2 last year sales versus Q2 this year sales. On your question regarding the Xiaomi mix in our revenue, I think the number one self-branded products would continue to grow together with Xiaomi. So in the outgoing quarters, we would definitely expect that Xiaomi revenue would increase versus the current level. And that increase would also go into July and August. So basically it's going to be very much in Q3 and Q4. And on the Xiaomi mix, obviously it's going to our self-branded products, it's also going to grow because as Wayne mentioned in his script that we also launched our T-Rex new product today and we are going to launch our new BIP and POP watches in June as well and not to mention the new GT series which are scheduled to be launched in Q3. So our self branded products launch time is also more skewed towards June and Q3, Q4. Uh, rather than last year, it was a little bit earlier in the year. And then, uh, so, so that actually creates some kind of a mismatch on the, the, the revenue, uh, outlook for our selves for this year. Right. Um, so what I'm saying is, um, on a full year, uh, basis, I think I just, uh, uh, mentioned that in the previous question, uh, answers as well. That full year revenue for the company should be, we're still looking at at least at the same level in absolute amount versus 2021 or with a single digit growth. And on the mix between Xiaomi and our self-branded products, for sure our self-branded products will take a bigger mix in this overall number. But of course, in the coming quarters in Q2, Q3, Q4, you will see a proportional increase of Xiaomi's weight in the overall revenue mix of ourselves. So I hope that gives you some flavor on the outlook for the year.
spk03: Right, very clear. Also, I have a second question regarding our own brand product. What kind of functional upgrade are we focusing on this year? And how would you expect this change our product ASP or margin profitability-wise due to these new upgrades? Thank you. OK.
spk07: Now, so let me try to answer the easy ones. Obviously, the product ASP, we definitely want to see increase of our self-branded products, and we do see an increase from Q4 last year to Q1 this year, and then this trend should continue, right? That's on the product ASP part. And on the self-branded products, I think, as you know, that we have different lineup of the self-branded products to kind of cater for different consumer states, right? For example, the newly launched T-Rex 2 product is very much focusing on outdoor and on, for example, the accuracy of the GPS and hardcore sports and outdoor activities. While our GT theory, which is actually one of our biggest launch which we're going to have, in Q3 is going to be very much towards the mass and which is creating kind of a competitive product for the Apple Watch and the Samsung Watch. We do have our low-end, the so-called deep and pop series, which are very much focused on the entry-level watch users. And these are very much the value products, which we use to address the demand of users the bigger mass who is very sensitive to price and to compete with all those potentially the white-labeled products. So different product lineup we have would have different appeal to different consumers. And I think most of the updates you will see this year from us is going to be coming from for sure the specs and the feature upgrade of the watch. That's number one, both from screen, from the battery standby time, et cetera, et cetera. And also it's going to come from the ZEPP OS, which we launched last year. And as we mentioned in our script before, we're creating an ecosystem using ZEPP OS and we're trying to make it more apps which are more appealing to the consumers. And I think the third one is definitely the health functions which we're going to have, be it on SPO2, be it on blood pressure measurements and other sensory updates of our watches. So those three hopefully is going to lift our ASP for our self-branded products.
spk03: Okay. Thank you, Leon, very much. Thank you.
spk01: Our next question will come from Clive Chong with Credit Suisse. You may now go ahead.
spk05: Hi. Good evening. Thank you for taking my question. My first question is a follow-up to Leon's comment just now on expansion in SEP OS. I think given the macro environment being challenging and we could see decline in shipments or slowdown in shipment growth at least, are we looking to accelerate the monetization of SEP OS in terms of new application offerings or app offerings? That's my first question. My second question is on the OPEX I think previously we have a target of achieving approximately $300 million, give or take, in terms of kind of OPEX per quarter. Given this lower or lower revenue this year, do we have any color or any planning on a target for this level amount of OPEX? Thank you.
spk07: uh thank you class i mean those are very good questions now so let me first comment on the zap os monetization uh yes uh for sure we are actually trying to make zap os one of the uh differentiating factors for our products compared with the others right and then uh uh we you you probably noticed that we have announced that uh We have different third-party OS actually working inside the dev OS, for example, Spotify, for example, GoPro, and we're going to actually add a few more of those popular apps which are helping the users and which are being appreciated by the users. We're not going to just go in for the mere amount of amount. We're actually going for the quality. And we do have certain services which we actually went online in a small handful of countries by Q4 last year, which is our sleep and focusing type of services, which is actually connecting the hardware together with the AI-powered music to help you to sleep better and focus more. That type of functionality, we're actually rolling it out as we speak in more geographies as we speak. Obviously, we'll definitely try to widen the use of DevOps and actually try to build and link more popular third-party apps towards our DevOps. Hopefully, that answers your first question. Move to the OPEX. Our OPEX in the past quarters has always been hovering around $300 million, give or take, per quarter. In certain quarter, if the top line is going way above our threshold, we may allow the team to spend a little bit more. But if you take an average, we're actually below the line of $300 million per quarter for last year. And then the same goes for this year. And then we're actually signaling a right-sizing of our cost, and we are actually trying to make a step down on this cost level as well. But you might, because a lot of this is actually linking to people, right? And then even if you want to right-size the people, you know that you need to incur cost first before you see a step change on the cost base. We're doing that as we speak, so in Q2, you probably would still see a similar kind of 300 million mark for the cost, but then you should be able to see a step down from Q3 onwards on the cost level so that we can achieve a rebound and capture the upside once the demand comes back. If you're looking for a guidance on how big that step down would be, I think for the time being, you can use a range of 10% to 15% versus its current level, which we reported in Q1.
spk05: Okay. Thank you very much. Very clear. Thanks, Nir.
spk01: Again, if you have a question, please press star then 1. Our next question will come from Abhishek Sahoo with Templeton. You may now go ahead.
spk00: Yeah, hi, thanks for taking my question. So the first question I have is on the mix in the current quarter. What is the growth that you're seeing in Amazfit? And going forward in the coming quarters, what kind of growth would you expect to sustain in the Amazfit products?
spk07: Yeah, so I mean, very good question. So the Q1 number is kind of a slow quarter because from a seasonality perspective, Q1 is actually also the lowest demand quarter for the consumers. So, and this year Q1, as I mentioned in the script, we're kind of having a perfect storm whereby there's Ukraine and Russia conflict. And then there's also a lockdown of our factory in Shenzhen for a week towards the end of the quarter. So that all compounded together, it kind of hammered our revenue for Q1, not only the Xiaomi ones, but more so on our self-branded products. So if you actually strip out all that effect, I would say our self-branded products should continue to grow Maybe not at the double-digit growth rate which we reported last year, but at least it should be a growth versus a decline which we reported this year. And if you look at the outlook for Q2, obviously we already see that the supply chain, the lockdown kind of yeast in China, and that all have a positive impact on us. so that the self-branded product sales for sure is going to be bigger than Q1. But whether or not it's going to be on par with last year, for sure that is something which we're working towards. And then for the full year number for the self-branded products, I think we still want to change the mix overall. So basically, as I mentioned in the previous answers towards the other analysts, at this moment in time, we're still looking at from an absolute amount perspective, overall company's revenue will be at least flat versus 2021. or with a small single-digit growth for the year. To achieve that, that will be all coming from our self-branded products growth. From a seasonality perspective, I think what you would see is that Q1 will be lowest, Q2 gradually improving, and then Q3, Q4 will be the quarters which is going to make the year and which are also traditionally the high seasons giving the prime day sales as well as the double 11 and Christmas sales in Q3 and Q4. I hope that gives you a color for how you look at the revenue growth and the mix for this year.
spk00: Got it. Thanks, Leon. Also, just on a related point, while the mix continues to shift in favor of the self-branded products. Shouldn't that, in terms of percentage margins, shouldn't that lead to a much higher number than the 20% that we are currently reporting? I would have thought that the self-branded products come at a much higher margin, right?
spk07: That should, Abhijit. I mean, that's a good question. So what you saw here is that already versus Q4, there's a step change. So there's already 1% increase on the overall margin versus Q4. And Q4, our self-branded product was already accounted for more than 60% of the mix, right? um so and and and q1 uh there were certain one-offs for example the freight cost was extremely high uh versus uh uh the the wrong rate we had in 2021 because of the lockdown and those type of uh uh marco issues but then that those factors are also gradually going away in q2 and then as we go into the second half of the year so what i'm saying is that you would definitely see from a seasonality perspective also the self-branded products together with the new product launch which there was no there was zero in q1 and there's going to be a few of that in q2 and then there's going to be a lot of that in q3 then this effect would definitely push the gross margin of self-branded products up in Q2 and then also gradually going up in Q3 and Q4. So yes, to answer your question, I think you would see the bottom of the gross margin now and that that should gradually going up as we entered into the second half of the year.
spk00: Understood. Thanks. And another issue that I wanted to understand is you know, just the quantum of the buyback that we have done so far. You know, if we were to go by, you know, your expectations for the full year and gradual improvement through the year, you know, shouldn't we accelerate the pace of buybacks, you know, if we believe that the business is undervalued, right? So that is one. And, you know, also, you know, any updates from you on the ADR listing and what are the scenarios that we are looking at currently? Is there any risk of a delisting at all in your view?
spk07: Yeah. So let me first comment on the buyback. Yes, so we're actually continuing our buyback. And then to be honest, by March 31st, March 31st, that was the number 6.9 million. And we continue to buy back the shares as we speak. I think by the end of Q2, when we publish our Q2 results, you will definitely see that number going up. And we will continue with the buyback as we move towards the second half of this year. And then we do still have the space to do that. So that will definitely committed and continue to do so. And with regard to the listing risk, as you mentioned, I think that's a systematic risk which is overhand across all the Chinese tech companies. We're actually monitoring the situation very closely, and then we're considering different options including the second listing in Hong Kong, and working closely with our audit firms to get the PCAOB clearance. So those are being worked upon as we speak, and if there's updates, for sure, we'll push out a release on that front. But I guess in the short, middle term, we don't see any risk or negative impact from that. Or to be, or take another, yeah, to say that at least we think our company is undervalued and that's why we'll continue to do the buyback as we committed to do.
spk00: Got it, got it. Finally, from my side, how should we think about the Xiaomi relationship evolving? If the smart bands as a category were to continue declining and if we are not expanding the relationship into other categories, then how should we think about the engagement with Xiaomi? Are we Are we in discussions for other product lines, for other categories? What could be the nature of our relationship going forward, please?
spk07: No, so our relationship with Xiaomi is and has always been very strong, right? So that's why we launched the Mi Band 7 today together with the CEO of Xiaomi, right? and that relationship will remain strong, as mentioned by our CEO, and then we're already working on the next generation band for next year. We're done on doing that already, right? And then to answer the second part of your question, for sure we're exploring with them different form factors of products and on different categories, but that's still in discussion and we cannot say too much, unfortunately, in this call. But then whenever there's a progress on that, we will definitely issue a separate press release on it.
spk00: Got it. Thank you so much, Leon, and all the very best.
spk06: Thank you.
spk01: As there are no further questions, Now I'd like to turn the call back over to the company for closing remarks.
spk02: Thank you once again for joining us today. If you have further questions, please feel free to contact JAP's Investor Relations Department through the contact information provided on our website. This concludes this conference call. You may now disconnect your line. Thank you.
Disclaimer